TD Cowen Adjusts Price Target on DaVita to $139 From $136
MT NewswiresMay 7 20:01
DaVita Analyst Ratings
BenzingaMay 6 23:21
Barclays Adjusts Price Target on DaVita to $150 From $133
MT NewswiresMay 3 20:21
Barclays Keeps Their Hold Rating on DaVita (DVA)
TipRanksApr 15 16:26
Analysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX) and DaVita (DVA)
TipRanksApr 3 16:01
Deutsche Bank Adjusts DaVita Price Target to $135 From $120, Maintains Hold Rating
MT NewswiresMar 8 23:48
DaVita Analyst Ratings
BenzingaMar 7 05:05
Barclays Initiates Coverage On DaVita With Equal-Weight Rating, Announces Price Target of $133
BenzingaMar 7 05:09
TD Cowen Sticks to Their Hold Rating for DaVita (DVA)
TipRanksFeb 26 09:55
DaVita Analyst Ratings
BenzingaFeb 20 22:16
DaVita Analyst Ratings
BenzingaFeb 16 00:53
UBS Adjusts DaVita Price Target to $145 From $134, Maintains Buy Rating
MT NewswiresFeb 16 00:29
DaVita Analyst Ratings
BenzingaFeb 15 03:50
UBS Adjusts DaVita Price Target to $134 From $113, Maintains Buy Rating
MT NewswiresFeb 15 01:29
DaVita Analyst Ratings
BenzingaFeb 14 21:13
Maintaining a Sell Rating on DaVita Amid Long-Term Growth Concerns and Cost Management Challenges
TipRanksFeb 14 18:45
UBS Maintains Buy on DaVita, Lowers Price Target to $113
BenzingaNov 17, 2023 23:58
DaVita Analyst Ratings
BenzingaNov 17, 2023 23:56
Deutsche Bank Adjusts DaVita Price Target to $90 From $113, Maintains Hold Rating
MT NewswiresNov 8, 2023 23:43
DaVita's Strong Quarter Overshadowed by Volume Normalization and Pricing Concerns: A Sell Rating Reiteration
TipRanksNov 8, 2023 18:57
No Data
No Data